GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Degree of Financial Leverage

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Degree of Financial Leverage : 1.16 (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Degree of Financial Leverage?

Degree of Financial Leverage (DFL) measures the percentage change in EPS for a unit change in Earnings Before Interest and Taxes (EBIT). Oxford Cannabinoid Technologies Holdings's Degree of Financial Leverage for the quarter that ended in Oct. 2023 was 1.16. The higher Degree of Financial Leverage, the more volatile earnings will be.

The industry rank for Oxford Cannabinoid Technologies Holdings's Degree of Financial Leverage or its related term are showing as below:

FRA:0CB's Degree of Financial Leverage is ranked worse than
67.61% of 1488 companies
in the Biotechnology industry
Industry Median: 0.97 vs FRA:0CB: 1.16

Oxford Cannabinoid Technologies Holdings Degree of Financial Leverage Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Degree of Financial Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Degree of Financial Leverage Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Degree of Financial Leverage
- - 1.80 3.61 0.43

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Degree of Financial Leverage Get a 7-Day Free Trial Premium Member Only 3.61 0.75 0.46 0.43 1.16

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's Degree of Financial Leverage

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Degree of Financial Leverage, along with its competitors' market caps and Degree of Financial Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Cannabinoid Technologies Holdings's Degree of Financial Leverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Degree of Financial Leverage distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Degree of Financial Leverage falls into.



Oxford Cannabinoid Technologies Holdings Degree of Financial Leverage Calculation

Oxford Cannabinoid Technologies Holdings's Degree of Financial Leverage for the quarter that ended in Oct. 2023 is calculated as:

Degree of Financial Leverage=% Change in Earnings per Share (Diluted)**/% Change in EBIT
=( -0.005 (Oct. 2023) / -0.006 (Oct. 2022) - 1 )/( -5.577 (Oct. 2023) / -7.944 (Oct. 2022) - 1 )
=-0.1667/-0.298
=0.56***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EPS and EBIT was used to calculate Degree of Financial Leverage.
*** Please be aware that the Degree of Financial Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Oxford Cannabinoid Technologies Holdings  (FRA:0CB) Degree of Financial Leverage Explanation

Degree of Financial Leverage (DFL) is a leverage ratio that measures the sensitivity of a company’s Earnings per Share (EPS) to fluctuations in its operating income, also referred to as Earnings Before Interest and Taxes (EBIT), resulting from adjustments in its capital structure. DFL is an essential tool for companies to assess the appropriate level of debt or financial leverage in their capital structure. When EBIT remains relatively stable, it results in stable earnings and earnings per share. In such cases, the company may consider taking on substantial debt. However, for companies operating in industries with significant fluctuations in EBIT, it is advisable to keep debt at a manageable level.

The higher Degree of Financial Leverage, the more volatile earnings will be. Because interest is a fixed expense, leverage can amplify earnings and EPS. This is beneficial when EBIT is growing, but it can become problematic in tough economic conditions when EBIT is under pressure.

Be Aware

The use of financial leverage varies across different industries and business sectors, and the application of Degree of Financial Leverage (DFL) should be adjusted accordingly.


Oxford Cannabinoid Technologies Holdings Degree of Financial Leverage Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Degree of Financial Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines